Renhe Pharmacy Co Ltd

000650

Company Profile

  • Business description

    Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicines, raw materials, and health-related products, including oral solid dosage forms, oral liquid dosage forms, large-volume injections, small-volume injections, external washes, liniments, suppositories, ointments, and other dosage forms of pharmaceuticals and health-related products. The company's main products include: Renhe Kelike, Youkadan series, Fuyanjie series, Da Huo Luo capsules, Shanliang eye drops, Qinghuo capsules, and Zhengwei capsules.

  • Contact

    No. 998 Honggu Middle Avenue, Greenland Central Plaza
    18th Floor, Yuanchuang International, Zone B
    Honggutan New District, Jiangxi Province
    Nanchang330038
    CHN

    T: +86 79183896755

    http://www.renheyaoye.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    4,923

Stocks News & Analysis

stocks

Nvidia: Hugging Face acquisition both a wise offensive and defensive move

We think this improves Nvidia’s position within the open-source community.
stocks

Anthropic’s IPO will be huge—and risky. Here are the challenges investors should watch

Part two of a Q&A with PitchBook senior analyst Harrison Rolfes about Anthropic, the AI giant’s challenges, and how much it’s worth.
stocks

Chart of the Week: China demand for copper falls amidst record rally

Elevated copper prices raise valuation questions.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,196.0054.60-0.59%
CAC 408,278.777.63-0.09%
DAX 4026,046.4043.080.17%
Dow JONES (US)53,374.64311.47-0.58%
FTSE 10010,831.090.43-0.00%
HKSE25,650.87437.561.74%
NASDAQ26,450.92133.14-0.50%
Nikkei 22565,020.94806.461.26%
NZX 50 Index13,974.18128.000.92%
S&P 5007,708.6139.10-0.50%
S&P/ASX 2009,005.9064.30-0.71%
SSE Composite Index3,930.1211.97-0.30%

Market Movers